About this data
What it is
ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
Who files it
The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
How current
We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
Terms
ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
Worth knowing
A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
Not to be confused with
FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.

All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.

Studies updated per day, last 30 days

0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0
0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0

All industry-sponsored studies Sponsor matched to a public company

By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.

Latest clinical trial updates

Reset

Showing: ticker BSX · All recent updates

Studies by the date their record was last updated.

Latest clinical trial updates
UpdatedStudySponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).EnrolledPrimary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.Source
Nov 13, 2026Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clini…
NCT07209852 · Bradycardia, Atrioventricular Block
Pacemaker lead
BSX
Boston Scientific Corporation
—Active, not recruiting141Aug 31, 2029Registry ↗
Nov 13, 2026Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain
NCT06827262 · Chronic Low-back Pain, Vertebrogenic Pain Syndrome
Intracept™ Intraosseous Nerve Ablation
BSX
Boston Scientific Corporation
—Recruiting1,500Jul 2034Registry ↗
Nov 13, 2026Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)
NCT04032470 · Essential Tremor
Deep Brain Stimulation Systems (DBS)
BSX
Boston Scientific Corporation
—Recruiting500Dec 2039Registry ↗
Nov 13, 2026RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness o…
NCT01719055 · Pain
neurostimulation system
BSX
Boston Scientific Corporation
—Recruiting4,800May 2035Registry ↗
Nov 12, 2026Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control
NCT07190807 · Chronic Pain, Intractable Pain
Boston Scientific WaveWriter Alpha™ SCS Systems
BSX
Boston Scientific Corporation
Not applicableRecruiting70Nov 2027Registry ↗
Nov 12, 2026Stone and Laser Therapies Post-Market Study (SALT)
NCT06982235 · Benign Prostate Hypertrophy(BPH), Renal Calculi
Ureteroscope system, Laser system
BSX
Boston Scientific Corporation
—Active, not recruiting238Feb 2029Registry ↗
Nov 12, 2026Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis
NCT06750146 · Malignant Biliary Stenosis
Hot AXIOS™ Stent and Electrocautery Enhanced Delivery System
BSX
Boston Scientific Corporation
Not applicableSuspended162May 2027Registry ↗
Nov 12, 2026SIMPLAAFY Clinical Trial
NCT06521463 · Atrial Fibrillation, Stroke
WATCHMAN FLX Pro LAAC Device
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting1,857Jul 7, 2026Registry ↗
Nov 12, 2026SpaceIT Hydrogel System for Perirectal Spacing
NCT06451614 · Prostate Cancer
SpaceIT Hydrogel System, Commercially available Boston Scie…
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting230Sep 30, 2026Registry ↗
Nov 12, 2026Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer
NCT04905069 · Prostate Cancer
SpaceOAR Vue System
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting500Dec 2027Registry ↗
Nov 12, 2026REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NCT04838769 · Benign Prostatic Hyperplasia (BPH)
REZŪM, alpha blocker and 5-alpha reductase inhibitor
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting155Dec 11, 2025Registry ↗
Nov 12, 2026Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Ant…
NCT04798768 · Tachycardia, Ventricular, Arrhythmia, Ventricular
mCRM Therapy System
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting297May 6, 2024Registry ↗
Nov 12, 2026IT Matters: The Erectile Restoration Registry
NCT04200937 · Erectile Dysfunction
Tactra Malleable, Spectra™ Concealable Penile Prothesis
BSX
Boston Scientific Corporation
—Enrolling by invitation450Jan 2031Registry ↗
Nov 12, 2026A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)
NCT04192591 · Lumbar Spinal Stenosis
Superion™ IDS device
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting166Feb 2038Registry ↗
Nov 12, 2026Intra-operative Pancreatoscopy in Patients With IPMN
NCT03729453 · Intraductal Papillary Mucinous Neoplasm
SpyGlass
BSX
Boston Scientific Corporation
—Active, not recruiting100Aug 11, 2022Registry ↗
Nov 12, 2026Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT03664609 · Parkinson Disease, Essential Tremor
Deep Brain Stimulation
BSX
Boston Scientific Corporation
—Recruiting5,000Dec 2028Registry ↗
Nov 12, 2026Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
NCT02071134 · Parkinson's Disease
Deep Brain Stimulation (DBS)
BSX
Boston Scientific Corporation
—Recruiting1,500Dec 2038Registry ↗
Nov 12, 2026Patient Retrospective Outcomes (PRO)
NCT01550575 · Chronic Pain
Non Boston Scientific Systems, Boston Scientific Systems
BSX
Boston Scientific Corporation
—Recruiting15,000Dec 2030Registry ↗
Nov 9, 2026The Evaluation of User Experience With FARAVIEW™ Technology of the OPAL HDx™ Mapping System When Us…
NCT07925359 · Atrial Fibrillation (AF), Paroxysmal AF
Ablation Treatment with FARAPULSE™ Pulsed Field Ablation (P…
BSX
Boston Scientific Corporation
Not applicableNot yet recruiting200Oct 2027Registry ↗
Nov 6, 2026Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
NCT07639684 · Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
ESG with OverStitch
BSX
Boston Scientific Corporation
Not applicableNot yet recruiting50Jul 2029Registry ↗
Nov 6, 2026Endo-SPONGE for Treatment of Anastomotic or Hartmann's Stump Leakages in Lower Pelvic Area
NCT07035431 · Anastomotic Leaks, Hartmanns Stump Leakage
Endo-SPONGE
BSX
Boston Scientific Corporation
Not applicableRecruiting66Dec 2028Registry ↗
Nov 6, 2026Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
NCT06686485 · Concomitant Procedures, Atrial Fibrillation
FARAPULSE™ PFA system and WATCHMAN LAAC Delivery Systems
BSX
Boston Scientific Corporation
—Active, not recruiting433Oct 31, 2026Registry ↗
Nov 4, 2026Safety and Effectiveness of Orbera365™ Intragastric Balloon System
NCT07062094 · Obesity
Intragastric Balloon
BSX
Boston Scientific Corporation
—Recruiting200Apr 7, 2028Registry ↗
Nov 4, 2026AXIOS™ Gastroenterostomy for Gastric Outlet Obstruction IDE
NCT06174805 · Gastric Outlet Obstruction
AXIOS(TM) Stent and Electrocautery Enhanced Delivery System
BSX
Boston Scientific Corporation
Not applicableSuspended67Sep 2027Registry ↗
Nov 3, 2026Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchroniz…
NCT07069738 · Heart Failure - NYHA II - IV
CRT-D with a Quadripolar LV lead, CRT-D with INGEVITY+ pace…
BSX
Boston Scientific Corporation
Not applicableRecruiting850Nov 2029Registry ↗
Nov 2, 2026A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of S…
NCT06492174 · In-Stent Restenosis
AGENT DCB 40 mm
BSX
Boston Scientific Corporation
Phase 3Active, not recruiting20Dec 19, 2025Registry ↗
Nov 2, 2026BoStOn SCientific Rhythm MAnagemenT REgiStry
NCT04823663 · Cardiac Disease
Implant, Electrophysiologic procedure
BSX
Boston Scientific Corporation
—Recruiting12,500Dec 31, 2030Registry ↗
Nov 2, 2026A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of S…
NCT04647253 · In-Stent Restenosis
AGENT DCB, PTCA balloon catheter
BSX
Boston Scientific Corporation
Phase 3Active, not recruiting600Oct 2, 2023Registry ↗
Oct 30, 2026A Post Approval Study to Evaluate Safety and Effectiveness of Multicompartmental Dosimetry Planning.
NCT07669727 · Hepatocellular Carcinoma (HCC)
TheraSphere
BSX
Boston Scientific Corporation
—Not yet recruiting140May 2028Registry ↗
Oct 30, 2026A Prospective, Multicenter, Single Arm Registry of ENROUTE NPS in Conjunction With Carotid WALLSTEN…
NCT07458243 · Carotid Artery Stenosis
transcarotid artery revascularization
BSX
Boston Scientific Corporation
—Not yet recruiting60Sep 30, 2027Registry ↗
Oct 30, 2026Combined CM and STN Stimulation for Motor Epilepsy
NCT07458217 · Motor Epilepsy
Deep brain stimulation
BSX
Boston Scientific Corporation
Not applicableRecruiting
was not yet recruiting
10May 31, 2028Registry ↗
Oct 30, 2026Dose Escalation Study Evaluating Safety of TheraSphere Prostate Cancer (PCa) Device
NCT06192758 · Prostate, Cancer
TheraSphere PCa
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting36Jan 2028Registry ↗
Oct 30, 2026A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients…
NCT05303467 · Glioblastoma Multiforme, Recurrent Glioblastoma
TheraSphere GBM
BSX
Boston Scientific Corporation
Phase 1Recruiting36Jan 31, 2027Registry ↗
Oct 30, 2026TheraSphere With Durvalumab and Tremelimumab for HCC
NCT05063565 · Hepatocellular Carcinoma
TheraSphere Y-90 glass microsphere therapy, Durvalumab (Imf…
BSX
Boston Scientific Corporation
Phase 2Active, not recruiting100Jun 2027Registry ↗
Oct 28, 2026Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176 · Heart Failure, Congestive Heart Failure
Implant of investigational device system, Titration during…
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting118May 2014Registry ↗
Oct 27, 2026OPTION-EMEA Clinical Trial
NCT07349121 · Atrial Fibrillation (AF), Stroke Prevention in Patients Wit…
Concomitant pulsed field ablation (PFA) and left atrial app…
BSX
Boston Scientific Corporation
Not applicableRecruiting500Dec 2028Registry ↗
Oct 27, 2026OverStitch NXT Endoscopic Suture System
NCT07276815 · Weight Loss
OverStitch NXT Endoscopic Suture System
BSX
Boston Scientific Corporation
Not applicableRecruiting136Oct 31, 2028Registry ↗
Oct 27, 2026Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
NCT07195708 · Weight Loss
Treatment group
BSX
Boston Scientific Corporation
Not applicableRecruiting144Jun 30, 2028Registry ↗
Oct 27, 2026FARAPULSE™ Pulsed Field Ablation System
NCT06762717 · Paroxysmal AF
FARAPULSE™ Pulsed Field Ablation system
BSX
Boston Scientific Corporation
—Active, not recruiting501Dec 31, 2027Registry ↗
Oct 27, 2026A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
NCT03736226 · Cardiovascular Diseases
SYNERGYTM Stent System
BSX
Boston Scientific Corporation
—Active, not recruiting2,000Aug 1, 2024Registry ↗
Oct 26, 2026PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
NCT07106970 · Persistent Atrial Fibrillation
Linear ablation, PVI alone
BSX
Boston Scientific Corporation
Not applicableRecruiting640Dec 30, 2027Registry ↗
Oct 26, 2026A Real-World Study of EkoSonic Endovascular System in Chinese Populations With Acute Pulmonary Embo…
NCT06819865 · Acute Pulmonary Embolism
EkoSonicTM Endovascular System
BSX
Boston Scientific Corporation
—Recruiting30May 30, 2028Registry ↗
Oct 23, 2026A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With El…
NCT07820930 · Atrial Fibrillation (AF), Persistent Atrial Fibrillation (P…
FARAFLEX Mapping and Pulsed Field Ablation System
BSX
Boston Scientific Corporation
Not applicableNot yet recruiting650Jul 2029Registry ↗
Oct 23, 2026Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrill…
NCT07575269 · Paroxysmal Atrial Fibrillation (PAF), Persistent Atrial Fib…
FARAFLEX Mapping and Pulsed Field Ablation (PFA) System
BSX
Boston Scientific Corporation
Not applicableRecruiting571Jul 20, 2028Registry ↗
Oct 23, 2026Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
NCT07444320 · Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillat…
FARAPULSE™ Pulsed Field Ablation (PFA) System
BSX
Boston Scientific Corporation
Not applicableRecruiting200Feb 2028Registry ↗
Oct 23, 2026A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wa…
NCT07187115 · Atrial Fibrillation (AF), Persistant Atrial Fibrillation
FARAPOINT Pulsed Field Ablation System, OptiMap System (non…
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting699Jan 2027Registry ↗
Oct 23, 2026A Registry on the FARAVIEW Technology of the OPAL HDx Mapping System When Used With the FARAWAVE NA…
NCT06808217 · Atrial Fibrillation, Pulsed Field Ablation
FARAPULSE Pulsed Field Ablation System
BSX
Boston Scientific Corporation
—Active, not recruiting550Apr 1, 2027Registry ↗
Oct 23, 2026Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With…
NCT06735534 · Persistent Atrial Fibrillation
FARAPULSE™ Pulsed Field Ablation System
BSX
Boston Scientific Corporation
Not applicableActive, not recruiting376Apr 2027Registry ↗
Oct 23, 2026FARAPULSE Workflow Assessment Registry
NCT06656884 · Atrial Fibrillation (AF)
BSX
Boston Scientific Corporation
—Active, not recruiting524Feb 15, 2027Registry ↗
Oct 23, 2026Feasibility Study of the FARAFLEX Mapping and PFA System
NCT06510556 · Atrial Fibrillation, Persistent Atrial Fibrillation
FARAFLEX Ablation Treatment, ELEVATE-COR Sub-study
BSX
Boston Scientific Corporation
Not applicableRecruiting250Feb 15, 2027Registry ↗

The newest 50 items, most recent first. Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:14 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances